Table 2.

Correlation between Shh, Gli1, MVD expression and clinicopathologic factors.

		Shh			Gli1			MVD
	n(%)	0–3	4–7	P	0–3	4–7	P	≤57	>57	P
Age
≤55	36(45%)	12	24	0.123	15	21	0.893	23	13	0.102
>55	44(55%)	8	36		19	25		20	24
Gender
Female	47(59%)	14	33	0.243	22	25	0.359	27	20	0.435
Male	33(41%)	6	27		12	21		16	17
Tumor size
≤4cm	50(63%)	9	41	0.063	25	25	0.082	30	20	0.152
>4cm	30(37%)	11	19		9	21		13	17
TNM stage
I,II	34(43%)	14	20	0.004	20	14	0.011	24	10	0.009
III, IV	46(57%)	6	40		14	32		19	27
Lymphatic metastasis
Negtive	30(37%)	16	14	0.000	20	10	0.001	23	7	0.001
Positive	50(63%)	4	46		14	36		20	30
Tumor recurrence
Negative	44(55%)	16	28	0.009	24	20	0.016	30	14	0.004
Positive	36(45%)	4	32		10	26		13	23

*P < 0.05 by X² test.